Donga ST announced that superbacteria target antibiotics 'Tedizolid’ got approval of U.S. FDA Anti -Infective Drugs Advisory Committee
On Apr 1, Donga ST announced that superbacteria target antibiotics 'Tedizolid (brand name SIVEXTRO ™) of which they exported techniques to Trius Therapeutics, got approval of U.S. FDA Anti -Infective Drugs Advisory Committee.
It was reported that on March 31 (U.S. local time), all 14 members of ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
